Trial Profile
Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2022
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 10 Jan 2017 New trial record